These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1167399)

  • 1. New pathway for metabolism of dopa.
    O'Leary MH; Baughn RL
    Nature; 1975 Jan; 253(5486):52-3. PubMed ID: 1167399
    [No Abstract]   [Full Text] [Related]  

  • 2. (18F) Fluoro-Dopa: a unique gamma emitting substrate for Dopa decarboxylase.
    Firnau G; Garnett ES; Sourkes TL; Missala K
    Experientia; 1975 Nov; 31(11):1254-5. PubMed ID: 1204761
    [No Abstract]   [Full Text] [Related]  

  • 3. Decarboxylation of 3,4-dihydroxyphenylalanine by oxyhemoglobin.
    Yamabe H; Lovenberg W
    Biochem Biophys Res Commun; 1972 May; 47(4):733-9. PubMed ID: 5063594
    [No Abstract]   [Full Text] [Related]  

  • 4. Properties of human red blood cell 1-3,4-dihydroxyphenylalanine decarboxylating activity.
    Dairman W; Christenson JG
    Eur J Pharmacol; 1973 May; 22(2):135-40. PubMed ID: 4736669
    [No Abstract]   [Full Text] [Related]  

  • 5. L-3,4-dihydroxyphenylalanine metabolism by the gut in vitro.
    Rivera-Calimlim L; Morgan JP; Dujovne CA; Bianchine JR; Lasagna L
    Biochem Pharmacol; 1971 Nov; 20(11):3051-7. PubMed ID: 5132112
    [No Abstract]   [Full Text] [Related]  

  • 6. The enzymatic decarboxylation of DOPA in human liver homogenates.
    Vogel WH; Snyder R; Hare TA
    Proc Soc Exp Biol Med; 1970 Jun; 134(2):477-81. PubMed ID: 5310151
    [No Abstract]   [Full Text] [Related]  

  • 7. An essential arginine residue at the binding site of pig kidney 3,4-dihydroxyphenylalanine decarboxylase.
    Tancini B; Dominici P; Barra D; Voltattorni CB
    Arch Biochem Biophys; 1985 May; 238(2):565-73. PubMed ID: 3994391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pyridoxal phosphate and L-dopapyridoxal phosphate on DOPA decarboxylase activity.
    Tran N
    Experientia; 1972 Sep; 28(9):1021-2. PubMed ID: 4665286
    [No Abstract]   [Full Text] [Related]  

  • 9. Limited tryptic proteolysis of pig kidney 3,4-dihydroxyphenylalanine decarboxylase.
    Tancini B; Dominici P; Simmaco M; SchininĂ  ME; Barra D; Voltattorni CB
    Arch Biochem Biophys; 1988 Feb; 260(2):569-76. PubMed ID: 3124758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reserpine-like effects of harmine on isolated adrenal medullary vesicles.
    Green HO; Slotkin TA
    Mol Pharmacol; 1973 Nov; 9(6):748-55. PubMed ID: 4148654
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of a minor pathway of L-dopa metabolism in the intestinal lumen using a decarboxylase inhibitor (Ro 4-4602).
    Bakke OM; Scheline RR
    J Pharm Pharmacol; 1974 May; 26(5):377-9. PubMed ID: 4152920
    [No Abstract]   [Full Text] [Related]  

  • 12. How does L-dopa work in parkinsonism?
    Sandler M
    Lancet; 1971 Apr; 1(7703):784. PubMed ID: 4101278
    [No Abstract]   [Full Text] [Related]  

  • 13. DOPA decarboxylase inhibition through the interaction of coenzyme and substrate.
    SCHOTT HF; CLARK WG
    J Biol Chem; 1952 May; 196(1):449-62. PubMed ID: 12980987
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism of putative transmitters in individual neurons of Aplysia californica: aromatic amino acid decarboxylase.
    Weinreich D; Dewhurst SA; McCaman RE
    J Neurochem; 1972 Apr; 19(4):1125-30. PubMed ID: 4401683
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of vitamin B6 to reverse the L-dopa effect in patients on a dopa decarboxylase inhibitor.
    Klawans HL; Ringel SP; Shenker DM
    J Neurol Neurosurg Psychiatry; 1971 Dec; 34(6):682-6. PubMed ID: 5158783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of L-DOPA perfusion concentrations and peripheral decarboxylase inhibition on dopa accumulation and decarboxylation in isolated perfused rat brains.
    Horst WD; Bautz G; Renyi E; Spirt N
    Neuropharmacology; 1973 Dec; 12(12):1145-51. PubMed ID: 4782694
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the metabolism of 14C-dopa in the hepatopancreas of decapod crustacean Upogebia littoralis.
    Marmaras VJ; Fragoulis EG
    Comp Gen Pharmacol; 1971 Mar; 2(5):52-8. PubMed ID: 5162655
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of ethanol on tryptophan hydroxylase activity from striate synaptosomes.
    Rogawski MA; Knapp S; MAndell AJ
    Biochem Pharmacol; 1974 Jul; 23(14):1955-62. PubMed ID: 4418689
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopa decarboxylase activity of the living human brain.
    Gjedde A; Reith J; Dyve S; LĂ©ger G; Guttman M; Diksic M; Evans A; Kuwabara H
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2721-5. PubMed ID: 1688340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity labeling of pig kidney 3,4-dihydroxyphenylalanine (Dopa) decarboxylase with N-(bromoacetyl)pyridoxamine 5'-phosphate. Modification of an active-site cysteine.
    Dominici P; Maras B; Mei G; Borri Voltattorni C
    Eur J Biochem; 1991 Oct; 201(2):393-7. PubMed ID: 1935936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.